Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.

Abstract: Cyclometallated iridium complexes having triphenylene or aza triphenylene and bulky alkyl substitution that can be used as emitters in OLEDs to improve the external quantum efficiency (EQE) and lifetime of OLEDs are disclosed.

Abstract: A novel compound is disclosed which includes a ligand LA of Formula II, wherein: ring B is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1 to X4 are each independently selected from the group consisting of C, N, and CR; at least one pair of adjacent X1 to X4 are each C and fused to Formula V where indicated by “”; X5 to X12 are each independently C or N; the maximum number of N within a ring is two; Z and Y are each independently selected from the group consisting of O, S, Se, NR?, CR?R?, SiR?R?, and GeR?R?; RB and RC each independently represents zero, mono, or up to a maximum allowed substitutions to its associated ring; each of RB, RC, R, R?, and R? is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, su

Abstract: Provided are organometallic compounds including a ligand LA of Formula I

Abstract: A compound having the formula Ir(LA)n(LB)3?n, having the structure Formula I, is disclosed. In Formula I, each of Z1, Z2, Z3, and Z4 is CR2; X is O, S, or Se; n is an integer from 1 to 3; R1, R2, R3, R4, and R5 each independently represent mono- to a maximum possible number of substitutions, or no substitution; R1, R2, R3, R4, and R5 are each independently selected from a variety of substituents; any two substitutions in R1, R2, R3, R4, and R5 are optionally joined to form a ring; at least one pair of substitutions in R1, R2, R3, R4, and R5 are joined together to form a bridge structure comprising a backbone structure that forms a fused first ring, which can be further substituted; and the backbone structure is saturated. Organic light emitting devices and consumer products containing the compounds are also disclosed.

Abstract: Provided are organometallic compounds having a structure of Also provided are formulations that include these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a metal coordination complex structure, where the compound is capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature is disclosed. The compound has a first ligand coordinated to a metal. The free-state of the first ligand has a first triplet energy T1 of EL at 77K, while the compound has a first triplet energy T1 of E at 77K, and the difference in energy (?E) between E and EL is ?250 meV. The compound has a triplet emission spectrum with a FWHM value of no more than 45 nm. Organic light emitting devices, consumer products, and formulations containing the compounds are also disclosed.

Abstract: Provided are transition metal compounds having 5-membered carbocyclic or heterocyclic ring in a unique configuration of fused rings per Formula I The compounds show improved phosphorescent emission in red to near IR region and are useful as emitter materials in organic electroluminescence device.

Abstract: Novel phosphorescent OLED emitters based on metal complexes with indolizine-derived heterocycles as ligands are disclosed. Structural variations of the ligands provide access to a variety of green, yellow and red emitters.

Abstract: A compound comprising a first ligand LA comprising a structure of Formula I, is provided. In Formula I, moieties A, B, C, and D are each independently a monocyclic ring or a multicyclic fused ring system; each of X1 to X8 is C or N; each independently represents a single bond or a double bond; each of L1, L2, L3, and L4 is independently a direct bond or a linking group; each R, R?, R?, RA, RB, RC, and RD is a hydrogen or a General Substituent; any two adjacent R, R?, R?, RA, RB, RC, and RD may be joined or fused to form a ring; and LA is coordinated to a transition metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Metal complexes with cyclic ligands having Formula (I), are disclosed. Ligands with cyclic structure are believed to be beneficial to the rigidity and stability of the metal complexes, which is desirable for improving OLED device performance.

Abstract: A compound having the formula: Formula I is disclosed. The compound is useful as emitters in OLEDs.

Abstract: Indolocarbazole materials with substitution attached at specific positions and methods to synthesize the same are disclosed. The materials are used as hosts for improving performance of organic electroluminescence devices.

Abstract: Provided is a compound including a first ligand LA of Formula I In Formula I, ring C is a 5- or 6-membered ring; each of X1 to X8 is C or N; one of X1 to X4 is C and is connected to ring C, and one of X1 to X4 is N and is coordinated to a metal M; Y is a divalent linker; K is a direct bond, O, or S; each R?, R?, RA, RB, and RC is hydrogen or a general substituent; at least one of RA or RB comprises an electron-withdrawing group; at least one of RB is a cyclic group; and metal M is selected from Os, Ir, Pd, Pt, Cu, Ag, and Au. Formulations, devices, and consumer products comprising the compound are also disclosed.

Abstract: A compound of a first ligand LA of Formula I, is provided. In Formula I, moieties A and B are each a monocyclic ring or a polycyclic fused-ring system; Z1 to Z4 are each C or N; K is a direct bond, O, or S; each RA and RB is independently a hydrogen or a General Substituent; at least one RA or RB is R*, wherein R* has a structure of Formula II, ---L-GeR1R2R3; L is a direct bond or an organic linker; and LA is coordinated to a metal M by the dashed lines; and metal M is selected from Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, or Cu.

Abstract: Provided are organometallic compounds comprising a first ligand LA which is based on a structure of fused five and six-membered rings according to Formula I as described herein and their various uses including as emitters in devices. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these compounds.

Abstract: Disclosed is a compound including a ligand LA of Formula I where each of moiety A and moiety B is independently a monocyclic or polycyclic ring structure including 5-membered and/or 6-membered carbocyclic or heterocyclic rings; where moiety B includes a structure of Formula II These compounds are useful as a component in the emissive layer of OLEDs.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: New organometallic complexes having bis- or tris-heteroleptic ligands and large aspect ratio in one direction and their use in OLEDs to enhance the efficiency is disclosed.

Abstract: A compound having a structure of Formula I, is provided. In Formula I, each of moieties B, C, and D is a ring or multicyclic ring system; each of X1, X2, X3, X4, X5, Y1, Z1, Z2, Z3, Z4, and Z5 is C or N; each of K1, K2, and K3 is a direct bond, O, or S; L1 and L2 are independently direct bonds or bivalent linking groups; each R, R?, RA, RB, RC, and RD is independently hydrogen or a substituent; any two substituents may be joined or fused together to form a ring; and at least one pair of RB, RC, or RD are joined to form a 5-membered heterocyclic ring. Formulations, OLEDs, and consumer products containing the compound are also provided.